BioCentury
ARTICLE | Clinical News

VT-1161 regulatory update

October 17, 2016 7:00 AM UTC

FDA granted Qualified Infectious Disease Product (QIDP) designation to VT-1161 from Viamet to treat recurrent vulvovaginal candidiasis. VT-1161 is in a Phase IIb trial for the indication (see BioCentu...